Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Obstructive myocardiopathy and pregnancy]

V Bascou1, J Ferrandis, V Bauer

  • 1Service de Gynécologie-Obstétrique, Hôpital Jean-Bernard, Poitiers.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|January 1, 1993
PubMed
Summary

Pregnancy in severe obstructive cardiomyopathy is manageable, with no increased mortality risk despite potential symptom worsening. Fetal risks are primarily associated with beta-blocker treatment and genetic inheritance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of oral tapentadol in cats.

Journal of veterinary pharmacology and therapeutics·2023
Same author

Determination of milk concentrations and pharmacokinetics of salicylic acid following acetylsalicylic acid (aspirin) administration in postpartum dairy cows.

Journal of dairy science·2022
Same author

Effects of activated neutrophils on isolated rings of rat thoracic aorta.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2011
Same author

Influence of fetal and parental factors on intrauterine growth measurements: results of the EDEN mother-child cohort.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

Pre-pregnancy body mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension, and birth outcomes.

Maternal and child health journal·2011
Same author

[Does the G spot exist?].

Gynecologie, obstetrique & fertilite·2010

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Genetics

Background:

  • Severe obstructive cardiomyopathy presents unique challenges during pregnancy.
  • Management strategies for pregnant patients with this condition require careful consideration.

Observation:

  • A case study details pregnancy management in a patient with severe obstructive cardiomyopathy on beta-blocker therapy.
  • Literature review indicates pregnancy does not elevate mortality risk in these patients.

Findings:

  • Functional symptomatology may worsen during pregnancy, but maternal mortality risk remains low.
  • Fetal risks are primarily linked to maternal beta-blocker treatment and the potential for genetic transmission of the cardiomyopathy.

Implications:

Related Experiment Videos

  • Pregnancy management in severe obstructive cardiomyopathy necessitates a multidisciplinary approach.
  • Recommendations for delivery conduct should prioritize maternal and fetal well-being.
  • Genetic counseling is crucial for affected families due to inheritance risks.